PRESS RELEASE published on 09/30/2024 at 10:17, 1 year 5 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 09/30/2024 at 07:35, 1 year 5 months ago AFYREN publie ses résultats financiers semestriels 2024 Résultats Financiers Partenariats Stratégiques Trésorerie Production Durable AFYREN NEOXY
BRIEF published on 09/30/2024 at 07:35, 1 year 5 months ago AFYREN publishes its 2024 half-year financial results Financial Results Strategic Partnerships Treasury Sustainable Production AFYREN NEOXY
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 5 months ago Informations privilégiées / Communiqué sur comptes, résultats AFYREN annonce ses résultats financiers semestriels 2024, avec des ajustements opérationnels pour atteindre la production en continu d'AFYREN NEOXY. Solide assise financière et avancées commerciales marquantes Résultats Financiers Partenariats Commerciaux Ajustements Opérationnels AFYREN Production En Continu
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 5 months ago Inside Information / News release on accounts, results AFYREN announces its 2024 half-year financial results, highlighting adjustments needed for continuous production of AFYREN NEOXY products. Solid financial base supports operations with €43 million in cash as of June 2024 Cash Position Financial Base AFYREN Continuous Production 2024 Half-year Financial Results
BRIEF published on 08/29/2024 at 07:50, 1 year 6 months ago AFYREN Signs Multi-Year Contract with US Nutraceutical Manufacturer Sustainability GreenTech Nutraceuticals AFYREN Bio-based Ingredients
BRIEF published on 08/29/2024 at 07:50, 1 year 6 months ago AFYREN signe un contrat pluriannuel avec un fabricant américain de produits nutraceutiques Durabilité Technologie Verte Nutraceutiques AFYREN Ingrédients Biosourcés
PRESS RELEASE published on 08/29/2024 at 07:45, 1 year 6 months ago Inside Information / Other news releases AFYREN signs multi-year commercial contract with US nutraceutical company for bio-based acids, tapping into fast-growing market. Contract underscores focus on natural, sustainable solutions for health & well-being Sustainable Solutions Nutraceuticals AFYREN Commercial Contract Bio-based Acids
PRESS RELEASE published on 08/29/2024 at 07:45, 1 year 6 months ago Informations privilégiées / Autres communiqués AFYREN annonce un nouveau contrat commercial aux États-Unis pour fournir des produits nutraceutiques biosourcés. La société utilise une technologie de fermentation circulaire unique Fermentation AFYREN Contrat Commercial Produits Nutraceutiques Biosourcés
BRIEF published on 07/09/2024 at 07:50, 1 year 8 months ago AFYREN atteint 2 millions d'heures de fermentation en laboratoire Innovation Biotechnologie Biomasse Fermentation AFYREN
Published on 03/23/2026 at 14:05, 1 hour 7 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour 12 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 7 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 2 hours 40 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 2 hours 42 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 15:05, 7 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:30, 42 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 42 minutes ago Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 08:10, 7 hours 2 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
